Duane Morris Attorney David Feldman on what to expect at the FDA hearings on CBD this week
At the Cannabis World Congress and Expo in New York City on Thursday the showroom floor was abuzz in anticipation of the upcoming Food and Drug Administration hearings on the regulation of CBD. The event, which features a number of prominent and emerging CBD companies coincides with Friday’s hearing — the first since the passage of the farm bill in 2018 which legalized the production of hemp.
At the public hearing on Friday, a number of interested parties are set to speak, including doctors, consumers, and industry insiders, many of whom are hoping to finally have some clarification from the FDA on what they can, and cannot do with CBD.
At the CWCBExpo, PotNetwork News caught up with attorney David Feldman who helps to head up the cannabis law group at the Duane Morris law firm. Feldman spoke openly about what he expects from Friday’s hearings, and what he thinks the industry will look like in the next few years.
“[They’re] either going to deem it to be a drug or decide it’s going to be a dietary supplement,” said Feldman, echoing the sentiments of the FDA in recent months concerning CBD.
Duane Morris is sending some of their top lawyers from their D.C. office to the hearings, as it looks to be one of the hottest tickets in town for the members of the cannabis industry.